Arbutus Biopharma

Arbutus Biopharma

Verified
Publicly-traded biopharmaceutical company

Launch date
Employees
Market cap
$416m
Net debt
(CAD184m)
Firm valuation
$419m (Public information from 2022)
Burnaby British Columbia (HQ)

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues--4.7m5.3m5.3m7.3m9.3m
% growth---14 %-38 %27 %
Profit--(50.7m)(147m)(63.3m)(70.7m)(82m)
% profit margin--(1086 %)(2763 %)(1188 %)(964 %)(879 %)
EV / revenue-25.3x36.5x27.8x44.0x42.4x32.8x
EV / EBITDA--4498.0x-2954.0x-2407.0x---
R&D budget57m43m45m47m---
R&D % of revenue--964 %881 %---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
N/AN/AIPO
N/ACAD5.1mPost IPO Equity
Not yet verified
$3mPost IPO Debt
Not yet verified
$116mPost IPO Equity
Total Funding-

Recent News about Arbutus Biopharma

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.